Clinical and molecular hepatology
Aspirin for Hepatocellular Carcinoma Prevention in MASLD: How Far Are We Ready to Proceed? : Editorial on "Aspirin and HCC risk in MASLD: Nationwide cohort study with genetic risk analysis".
Yang-Hyun Baek
Published: 202610.3350/cmh.2025.1482
No abstract available for this study.